Biotech Stock Still 700%: What Investors Should Do Today
A biotech stock still 700% has defied gravity, even as it slumps 30% this year. Learn how to read the signals, what a...
Explore the best Visa credit card with rewards and no annual fee. Enjoy effortless earning on every transaction you make.
9,364 articlesA biotech stock still 700% has defied gravity, even as it slumps 30% this year. Learn how to read the signals, what a...
NVIDIA CEO Jensen Huang predicts AI agents will infiltrate every function in every company, signaling a new phase for...
Nvidia trades around $199 per share as investors weigh whether the AI winner can also be a true value stock. The deba...
Delta Air Lines posted a notable weekly gain, with delta stock 9.38% this week, even as retail social chatter turned ...
Through March 21, 2026, VT is down less than 1% year-to-date while SPY slides about 3%, signaling a shift toward glob...
As Hormuz tensions surge, oil hits fresh highs and Bitcoin faces a renewed test of its ‘digital gold’ status. Analyst...
As of March 2026, the iShares U.S. Pharmaceuticals ETF is heavily keyed to two drugmakers, exposing investors to outs...
Solana sits at a pivotal juncture in 2026, with traders weighing a rising wedge against thinning volume and a stubbor...
BNB rebounds from a dip as aggressive spot activity returns, lifting price toward the mid-600s while futures open int...
A Needham note argues that Abercrombie & Fitch could surge as stabilizing sales, strong Hollister growth and aggressi...
Bitcoin holds near $70,000 as macro pressures and tight liquidity push price into a narrow range ahead of a potential...
UBS lifts industries $140 price target on CF Industries as nitrogen markets tighten amid supply disruptions. The move...